新型β受体阻滞剂塞利洛尔  

A NEW KIND OF SELECTIVE BETA-BLOCKER—CELIPROLOL

作　　者：黄震华 

机构地区：上海第二医科大学附属第九人民医院心血管病研究室 上海第二医科大学附属第九人民医院心血管病研究室 200011 200011

出　　处：《中国新药杂志》1993年第3期17-20,共4页Chinese Journal of New Drugs

摘　　要：塞利洛尔是一种新型的选择性β受体阻滞剂,具有β_2受体激动、α_2受体阻滞、扩血管、降脂和保护心功能作用,并具有药代动力学简单、副作用小等优点,有助于减少冠心病危险因素、提高病人生活质量,对治疗冠心病、心绞痛、高血压较为有利。Celiprolol is a new kind of selective β-blocker with β_2-agonistic andα_2-antagonistic activities.It is used in dilating blood vessel,decreasing serum lipids andlipoproteins,and protecting cardiac function.It has the advantage of pharmacokineticssimplicity and low adverse reactions.It may be helpful in reducing the risk fator ofcoronary heart disease and raising life quality,and favourable in treatment of anginapectoris and hypertension.

关 键 词：塞利洛尔 Β受体阻滞剂 

分 类 号：R972.9[医药卫生—药品]